ELV - CIK 0001156039
The table below shows Elevance Health, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $4.29B | $5.81B | $8.06B | $8.40B | $8.36B | $10.69B |
| Capital expenditure | $1.12B | $1.26B | $1.30B | $1.15B | $1.09B | $1.02B |
| Investing cash flow | -$1.34B | -$5.17B | -$5.57B | -$4.56B | -$9.64B | -$7.32B |
| Dividends paid | $1.53B | $1.51B | $1.40B | $1.23B | $1.10B | $954.00M |
Elevance Health, Inc. reported operating cash flow of $4.29B for fiscal year 2025. That is down 26.1% from $5.81B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $3.27B (FY 2016) to $4.29B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $2.60B | $2.90B | $2.68B | $2.32B | $1.90B | $2.70B |
| Financing cash flow | -$1.74B | $1.19B | -$3.35B | -$1.32B | $423.00M | -$2.57B |